These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27157996)

  • 1. Reply to Jae Heon Kim's Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Nov; 70(5):e141-e142. PubMed ID: 27157996
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Kim JH
    Eur Urol; 2016 Nov; 70(5):e139-e140. PubMed ID: 27157997
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73: The Search for Accurate Diagnostic Rates in Renal Mass Biopsy.
    Abel EJ
    Eur Urol; 2016 Jun; 69(6):e117-8. PubMed ID: 26778464
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Lorenzo Marconi, Steven MacLennan, Thomas B.L. Lam, et al's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Derweesh IH; Mir MC; Autorino R
    Eur Urol; 2017 Sep; 72(3):e61-e62. PubMed ID: 28642021
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96.
    Gacci M; Vignozzi L; Corona G; Serni S; Maggi M
    Eur Urol; 2017 Apr; 71(4):e119-e120. PubMed ID: 27816298
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Bora Lee and Jae Heon Kim's Letter to the Editor re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402-7.
    Uren AD; Cotterill N; Harding C; Hillary C; Chapple C; Klaver M; Bongaerts D; Hakimi Z; Abrams P
    Eur Urol; 2018 Jan; 73(1):e15-e16. PubMed ID: 28801128
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17.
    Mir MC; Derweesh IH; Autorino R
    Eur Urol; 2017 Nov; 72(5):e129-e130. PubMed ID: 28528815
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Julien Dagenais, Matthew J. Maurice, Pascal Mouracade, Onder Kara, Ercan Malkoc, Jihad J. Kaouk. Excisional Precision Matters: Understanding the Influence of Excisional Volume Loss on Renal Function After Partial Nephrectomy. Eur Urol 2017;72:168-70.
    Dagenais J; Kaouk JH
    Eur Urol; 2017 Nov; 72(5):e133-e134. PubMed ID: 28558943
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to So-Ryoung Lee, Byoung-Won Park, and Jae Heon Kim's Letter to the Editor re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9.
    Gratzke C; Siddiqui E
    Eur Urol; 2019 Mar; 75(3):e59-e60. PubMed ID: 30773205
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
    Verhagen PCMS; Boevé ER
    Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Milan Hora's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 Oct; 76(4):e97. PubMed ID: 31255422
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 Jun; 75(6):e177-e178. PubMed ID: 30827695
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to M.V. Meng's Letter to the Editor re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9 and P.L. Steinberg et al. re: H. Baumert et al. The use of polymer (Hem-o-lok) clips for management of the renal hilum during laparoscopic nephrectomy. Eur Urol 2006;49:816-9. Eur Urol 2007;51:572-3.
    O'Kane HF; Nambirajan T
    Eur Urol; 2007 May; 51(5):1449. PubMed ID: 17229516
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Maxine Sun, Lorenzo Marconi, Tim Eisen, et al. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol 2018;74:611-20: Systematic Review Findings on the Role of Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma.
    Hwang EC; Risk MC; Dahm P
    Eur Urol; 2019 Mar; 75(3):e67-e68. PubMed ID: 30466889
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Chen Cai, Huamao Ye, and Bing Liu's letter to the editor re: Francesco Greco, Riccardo Autorino, Koon H. Rha, et al. Laparoendoscopic single-site partial nephrectomy: a multi-institutional outcome analysis. Eur Urol 2013;64:314-22.
    Greco F; Autorino R
    Eur Urol; 2013 Aug; 64(2):e33-4. PubMed ID: 23628494
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Philipp Dahm, Vikram Narayan, and Jae Hung Jung's Letter to the Editor re: Richard J. Sylvester, Steven E. Canfield, Thomas B.L. Lam, et al. Conflict of Evidence: Resolving Discrepancies When Findings from Randomized Controlled Trials and Meta-analyses Disagree. Eur Urol 2017;71:811-9.
    Lam TBL; Sylvester RJ; Canfield SE; Marconi L; MacLennan S; Yuan Y; Omar MI; N'Dow J
    Eur Urol; 2017 Oct; 72(4):e93-e94. PubMed ID: 28427786
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Pascal Mouracade's letter to the editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Oct; 68(4):e84-5. PubMed ID: 26058957
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. Eur Urol 2015;67:252-9.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):e21-2. PubMed ID: 25257031
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.'s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610.
    Yip W; Ghoreifi A; Djaladat H
    Eur Urol Oncol; 2023 Dec; 6(6):637. PubMed ID: 37316397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.